Advances in glucocorticoid-induced osteoporosis - Wikidata - wikimedia - TriplyDB

Advances in glucocorticoid-induced osteoporosis

Advances in glucocorticoid-induced osteoporosis

http://www.wikidata.org/entity/Q34975913

about

Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling Management of glucocorticoid-induced osteoporosis: clinical data in relation to disease demographics, bone mineral density and fracture risk.Minireview: nuclear receptor regulation of osteoclast and bone remodeling.Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.Clinical role of bisphosphonate therapy.Tanshinone IIA blocks dexamethasone-induced apoptosis in osteoblasts through inhibiting Nox4-derived ROS production.Understanding leptin-dependent regulation of skeletal homeostasis Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report miR-135b expression downregulates Ppm1e to activate AMPK signaling and protect osteoblastic cells from dexamethasone.Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone.microRNA-25 targets PKCζ and protects osteoblastic cells from dexamethasone via activating AMPK signaling Osteoporosis and fractures in systemic lupus erythematosus.Management of glucocorticoid-induced osteoporosis.Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.Biomarkers of cartilage and surrounding joint tissue.Management of osteoporosis in rheumatoid arthritis patients.The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.EGFR-AKT-mTOR activation mediates epiregulin-induced pleiotropic functions in cultured osteoblasts.P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.Current evidence on vitamin D deficiency and kidney transplant: What's new?Osteoinductive effects of preoperative dexamethasone in human dental pulp stem cells primary culture Sulforaphane reverses glucocorticoid-induced apoptosis in osteoblastic cells through regulation of the Nrf2 pathway.Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone.Polygonum multiflorm alleviates glucocorticoid‑induced osteoporosis and Wnt signaling pathway.P21(Waf1/Cip1) depletion promotes dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells by inhibiting the Nrf2/HO-1 pathway.microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1.Glucocorticoids, Inflammation and Bone.Immune Suppressive and Bone Inhibitory Effects of Prednisolone in Growing and Regenerating Zebrafish Tissues.Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats.The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis

P2860

Q26821908-8400CFEE-605B-4D28-A9A1-8B7D1CDB6A7D Q27314920-5D019BFD-E3E1-4612-870E-8ADBBE114546 Q28554140-E6C8FAA4-B7F7-4C44-834D-59658AB9C035 Q30946308-8BAA2A76-3907-4342-9241-260451E58DEF Q35054970-78A1A459-5415-4147-92B9-EA4FFC7FDF2A Q35725177-3C6608F0-5392-4E19-9535-9F8C4261169B Q36311593-900ABC68-3074-4CF8-A9C5-D8B4C35035EC Q36375631-E449AC18-75B9-410E-909F-F1AC91A614A4 Q36439661-5AEEE989-EFAA-4ECE-802C-D5CACE46B82D Q36473722-2EDC5E6F-04C0-4CA3-94FD-BF955CD3B454 Q36602853-2C875F94-C082-4076-A668-644F31A2859E Q36800314-26D713B9-B374-4062-8408-7FBCF3EC9CCC Q36917821-5310C454-1D2E-47B2-AE24-5517CFCF45E9 Q37001737-CC33E971-8DE4-4B86-BAC6-13FF14FFEC41 Q37567212-48579F1D-3C51-4CE4-AEE9-641A9485F4C3 Q37688586-8B16E9A0-FFE6-4E47-8F82-8E68566BD5F3 Q37709337-951FD264-5993-456B-96DB-8A0603B06E9E Q37709453-524B1AD9-9F7E-49F5-9B58-F686C9303E42 Q37972874-4FFDE3E5-4FD6-492D-9AAC-4AD7DA27B1F1 Q38033444-61A78339-5762-4D2A-A5BC-35F3F62BADA9 Q38073889-A4445925-1CF0-4287-872B-B5B7FC4D3794 Q38239828-FB6124CD-8D4D-4319-B910-E4B032374CA9 Q38334318-B4904C37-0CBD-4545-A6BC-6A56D057125D Q38436495-1640EFED-F09D-47DA-8CFF-A08159588785 Q38676353-3A90AE39-54F9-4CAB-9BA2-B188FAC90B61 Q38956405-E83A5DB9-E72D-49BB-99C1-15825753568C Q39016683-CF9019A7-6C00-4E03-8194-12046A49DB49 Q39172404-8C0385D5-085A-4B09-96AE-23DE05AB63BB Q41609250-2779A488-5038-49DB-80EC-69CECDA2AC72 Q41785572-4DCD8B12-9936-4483-97C3-48A177C7A326 Q46909890-1F91D142-E7B0-4F07-94FF-9C0DABF1B467 Q47167976-F9008A15-2E15-409E-A246-336451C656BB Q47426896-077088B4-24CE-4247-B53A-5A2762F27D7E Q47757872-A8559AD1-7FF9-4CEE-A014-CD1AD8A23EDE Q50121276-0B1B6871-8194-434E-B5C5-227B73A45ADF Q50128187-55ECB728-F395-4983-ABF7-6621616BAD16 Q51805648-7F0BA2C9-8772-4035-9B2A-75D2CCA633B9 Q52860832-9544F3CF-B783-4FE8-B763-28E463FBED4B Q57153114-9F371E4D-817E-45F3-B3EC-BD3902512F6E

P2860

Advances in glucocorticoid-induced osteoporosis

http://www.wikidata.org/entity/Q34975913

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Advances in glucocorticoid-induced osteoporosis

@ast

Advances in glucocorticoid-induced osteoporosis

@en

Advances in glucocorticoid-induced osteoporosis

@nl

type

label

Advances in glucocorticoid-induced osteoporosis

@ast

Advances in glucocorticoid-induced osteoporosis

@en

Advances in glucocorticoid-induced osteoporosis

@nl

prefLabel

Advances in glucocorticoid-induced osteoporosis

@ast

Advances in glucocorticoid-induced osteoporosis

@en

Advances in glucocorticoid-induced osteoporosis

@nl

P1433

Q34975913-009D7809-E48A-4AE9-BDF9-6BD50E983743

P1476

Q34975913-1F91805A-E82A-4772-920F-968239374657

P2093

Q34975913-280BBC62-C91E-4F23-8B1F-BD0EB5418D5D

Q34975913-DAC80CAC-7075-4551-A6AB-FC1CF5D83AC6

P2860

Q34975913-0B8B8D6F-F485-452F-821D-FF63CC1DCFE3

Q34975913-0C587776-90CE-4693-8508-E7D554239B14

Q34975913-125F5355-AB16-4D9E-9745-CE7550A579C7

Q34975913-143C5714-070E-44E5-8E07-B56EFD3989AC

Q34975913-1510F829-2441-4158-B66F-CBFB279479CF

Q34975913-21D421D7-661F-4E1A-952D-7DA9B8BA11BF

Q34975913-33B6A245-F32D-4DEB-BC3D-1FA1348A05E4

Q34975913-374323A9-31C0-409C-84D3-A43911A42B72

Q34975913-3EB79CA2-BED8-465C-AA42-2B1E3A9367CB

Q34975913-3F8A8139-547B-472E-97C2-FB90A2885620

P2888

Q34975913-36B562B4-EC4C-4796-82F6-72178322B842

P304

Q34975913-A569ECC4-9E59-4528-A119-622780AD5B94

P31

Q34975913-32F60F47-266A-4547-8F85-82EE24689251

P356

Q34975913-216878F3-6697-401A-AC08-631D27CDD97F

P433

Q34975913-0C18E36F-0399-4CB1-AA01-974E24F24FFF

P478

Q34975913-14A3244F-06D1-4A20-BBD8-63C5401CD7A3

P50

Q34975913-69281DDA-8D9B-40AF-86FF-9E07FDBC6D79

P577

Q34975913-1E484677-EE9D-405B-BAC2-BE27D761417D

P5875

Q34975913-1D79340C-A4EF-4886-A23A-93F092EDA30F

P6179

Q34975913-530225EC-4FED-4532-A5D2-EAC3A0231479

P698

Q34975913-F1D2EB2A-9C02-4AFF-B236-124C9858F082

P921

Q34975913-F0D3CA30-84B0-4ACD-9802-225D0C3EB3CC

Q34975913-F4351AE4-2BFF-467B-A705-37EAE4A53CE0

P932

Q34975913-9714A10D-E10D-4B90-8FB4-1ACE66D97AD2

P356

S11926-011-0173-Y

P1433

Current Rheumatology Reports

P1476

Advances in glucocorticoid-induced osteoporosis

@en

P2093

Debby den Uyl

http://www.w3.org/2001/XMLSchema#string

Willem F Lems

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for preventing falls in older people living in the community

High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass.

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).

Rheumatoid arthritis, corticosteroid therapy and hip fracture.

Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation.

Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

P2888

s11926-011-0173-y

P304

233-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-011-0173-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Irene E. Bultink

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50251119

http://www.w3.org/2001/XMLSchema#string

P6179

1046426055

http://www.w3.org/2001/XMLSchema#string

P698

21365209

http://www.w3.org/2001/XMLSchema#string

P921

P932

3092927

http://www.w3.org/2001/XMLSchema#string